Joy Mangel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joy Mangel has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Abi Vijenthira
Division of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto Ontario Canada
2 shared publications - Allison M. Wilkin
Ottawa Hospital Research Institute, Ottawa ON, Canada
2 shared publications - Annette Elizabeth Hay
Canadian Cancer Trials Group, Queen's University, Kingston, Canada
2 shared publications Carolyn Owen
Division of Hematology and Hematological Malignancies, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada
2 shared publications- Curtis Cooper
Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada
2 shared publications Erinn McCarthy
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto ON, Canada
2 shared publications
Latest Publications
- 8 November 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (4) , 484.e1-484.e18
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
- 8 November 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (4) , 484.e1-484.e18
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
- Open Access
- 1 August 2013
- Published by Wiley in Case Reports in Hematology
- Vol. 2013, 1-5
Kidney and Pancreatic Extramedullary Relapse in Adult Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature
Extramedullary relapse of acute lymphoblastic leukemia (ALL) is rare and has been primarily reported in pediatric patients or hematopoietic stem cell transplant recipients. We report a case of a 62-year-old woman who presented with relapsed ALL involving her kidneys, pancreas, and bone marrow 2 years after completing chemotherapy with a standard ALL protocol. Unfortunately, her extramedullary disease progressed despite treatment. To the best of our knowledge, this is the first reported case of extramedullary relapse of B-cell ALL to the kidneys and pancreas occurring in an adult patient who had not previously undergone a hematopoietic stem cell transplant. A literature review of kidney and pancreatic extramedullary relapse in ALL is also included.
- 1 August 2013
- Published by Wiley in Case Reports in Hematology
- Vol. 2013, 1-5
Open AccessKidney and Pancreatic Extramedullary Relapse in Adult Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature
Extramedullary relapse of acute lymphoblastic leukemia (ALL) is rare and has been primarily reported in pediatric patients or hematopoietic stem cell transplant recipients. We report a case of a 62-year-old woman who presented with relapsed ALL involving her kidneys, pancreas, and bone marrow 2 years after completing chemotherapy with a standard ALL protocol. Unfortunately, her extramedullary disease progressed despite treatment. To the best of our knowledge, this is the first reported case of extramedullary relapse of B-cell ALL to the kidneys and pancreas occurring in an adult patient who had not previously undergone a hematopoietic stem cell transplant. A literature review of kidney and pancreatic extramedullary relapse in ALL is also included.